The DOI matches its Crossref record.
Prostacyclin: A Potent Antimetastatic Agent
Abstract
Metastasis is the principal cause of failures to cure human cancers. Prostacyclin is a powerful antimetastatic agent against B16 amelanotic melanoma cells. This effect, which may result from the platelet antiaggregatory action of prostacyclin, is potentiated by a phosphodiesterase inhibitor. Inhibitors of prostacyclin synthesis increase metastasis. Prostacyclin and agents that may increase endogenous prostacyclin production or prolong its activity are suggested as new antimetastatic agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells
Palumbo, J. S., Kombrinck, K. W., Drew, A. F., Grimes, T. S., Kiser, J. H., Degen, J. L., & Bugge, T. H. (2000) · Blood · doi:10.1182/blood.v96.10.3302 · Cited by 605
Wolfe, L. S. (1982) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1982.tb10847.x · Cited by 573
OKUYAMA, H. (1996) · Progress in Lipid Research · doi:10.1016/s0163-7827(96)00012-4 · Cited by 292
Platelets and cancer metastasis: A causal relationship?
Honn, K. V., Tang, D. G., & Crissman, J. D. (1992) · Cancer and Metastasis Reviews · doi:10.1007/bf01307186 · Cited by 289
Self-citationMONCADA, S. (1982) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1982.tb09186.x · Cited by 272
Metadata
- Authors
- Honn, K. V., Cicone, B., & Skoff, A.
- Venue
- Science
- Published
- 1981-06-12
- Volume
- 212
- Issue
- 4500
- Pages
- 1270-1272
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1981581994
- Cited by
- 331
- References
- 0
- FWCI
- 30.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prostacyclin: A Potent Antimetastatic Agent. https://app.cochat.ai/papers/10.1126/science.7015512
- The paper
- Honn, K. V., Cicone, B., & Skoff, A. (1981). Prostacyclin: A Potent Antimetastatic Agent. Science. https://doi.org/10.1126/science.7015512
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.